Merck & Co Puts A Date On Spinning Off Biosimilars

Plans Have Been Public For 12 Months

 
• By Dean Rudge
  
Spinning top
The Merck spin-off Organon will take residence in New Jersey. • Source: Shutterstock

More from Biosimilars

More from Products